Skip to content
NEW: CREATE AN AI-ASSISTED TENDER IN 2 MINUTES — TRY IT FREE
Back to search
alpha-cannabis – Fertigung

Manufacturer of GMP-compliant cannabinoid active ingredients (THC, CBD) and manufacturing kits for magistral formulation production in pharmacies and clinics

alpha-cannabis Logo

alpha-cannabis Pharma GmbH

Sandstraße 5A, 31749 AuetalNew on Amplifa

2016Founded
HRB 201343, AG StadthagenCommercial Register
1 locationAuetal (Lower Saxony)

About alpha-cannabis Pharma

alpha-cannabis Pharma GmbH is a German pharmaceutical company based in Auetal, Lower Saxony. Since its founding in 2016, the company has focused exclusively on the medical potential of the naturally occurring constituents of the cannabis plant (cannabinoids) and is thus one of the pioneers of the industry. The company develops, produces and supplies cannabis-based active ingredients (APIs) for therapeutic use as well as GMP-compliant, monograph-conform substances (DAC/DAB, Ph. Eur.) based on THC (dronabinol) and CBD. The portfolio includes Dronabinol Solution 25 mg/ml according to NRF 22.8., active ingredient substances in various pack sizes, manufacturing kits including an identification kit for Delta 9 THC as well as further cannabinoids (CBG, CBC, CBN) with purities from 99 % and a certificate of analysis (CoA). Customers are hospitals, clinics, pharmacies and the pharmaceutical industry; bulk deliveries as white label are additionally offered to the pharmaceutical, cosmetic and food industries. The company is registered with EUDRA as a manufacturer of GMP-compliant medicinal products and is subject to supervision by the BfArM.

Site
Auetal
Processes
Manufacture of APIs / pharmaceutical active ingredients (cannabinoids THC/CBD), Analytics / quality control (in-house analytics, identification of Delta 9 THC, CoA), Manufacture of pharmaceutical preparations (Dronabinol solution 25 mg/ml NRF 22.8., manufacturing, Consulting for physicians and pharmacists, Manufacture of magistral-formulation active ingredients (NRF 22.8.), Manufacturing kits incl. identification kit, Analytics, White label / private label bulk deliveries
Materials
Dronabinol (THC), Cannabidiol (CBD), Cannabigerol (CBG), Cannabichromene (CBC), Cannabinol (CBN)
Certificates
GMP, GMP-compliant manufacturing (EUDRA-registered), License under § 4 MedCanG, ISO 9001
Founded
2016
Industries
Pharmaceutical industry, Pharmacies, Clinics/hospitals, Cosmetics industry, Food industry
  1. 01

    Development and formulation creation

  2. 02

    Manufacture of cannabinoid active ingredients (APIs)

  3. 03

    In-house analytics and quality control with CoA

  4. 04

    Filling / manufacturing kits

  5. 05

    Distribution to pharmacies, clinics and pharmaceutical wholesalers

  6. 06

    White-label bulk deliveries

Active Ingredients and Substances

THC

Dronabinol (THC)

Active ingredient as a solution 25 mg/ml (NRF 22.8.) and as a substance in packs of 500 mg to 5000 mg.

CBD

Cannabidiol (CBD)

Active ingredient substance with over 99 % CBD, available as a 100-g pack.

CBG

Cannabigerol (CBG)

Non-GMP substance with 99 % purity in 1-g and 10-g packs.

CBC

Cannabichromene (CBC)

Non-GMP substance with 99 % purity in 1-g and 10-g packs.

CBN

Cannabinol (CBN)

Non-GMP substance with 99 % purity in 1-g and 10-g packs.

Location

Auetal

DE

Headquarters with production and analytics

Materials
THC, CBD, CBG, CBC, CBN
  • In-house analytics
  • Process engineering production facilities

Products and Substances

Dronabinol (THC) Solution 25 mg/ml NRF 22.8.
Dronabinol (THC) Solution 25 mg/ml NRF 22.8.Magistral formulation production · Pharmacies/clinics
Cannabidiol (CBD) Substance 100 g
Cannabidiol (CBD) Substance 100 gActive ingredient manufacture · Pharmaceutical industry

Inside the production

Consulting and service for professionals
Consulting and service for professionals
Use of medical cannabinoids in therapy
Use of medical cannabinoids in therapy
Identification kit for Delta 9 THC
Identification kit for Delta 9 THC
CBD product line
CBD product line
Further cannabinoids (CBG, CBC, CBN)
Further cannabinoids (CBG, CBC, CBN)
Cannabigerol (CBG) substance
Cannabigerol (CBG) substance

Industries

Pharmaceutical industryPharmaciesClinics/hospitalsCosmetics industryFood industry

Processes & technical limits

ProcessesToleranceMax. partWeightLot sizeMaterials
Manufacture of APIs / pharmaceutical active ingredients (cannabinoids THC/CBD)Engineering––––Cannabinoids (THC, CBD, CBG, CBC, CBN)
Analytics / quality control (in-house analytics, identification of Delta 9 THC, CoA)Testing––––Cannabinoids
Manufacture of pharmaceutical preparations (Dronabinol solution 25 mg/ml NRF 22.8., manufacturingAssembly––––Dronabinol (THC), Oily solution

Additional services

Consulting for physicians and pharmacistsManufacture of magistral-formulation active ingredients (NRF 22.8.)Manufacturing kits incl. identification kitAnalyticsWhite label / private label bulk deliveries

Reference customers

HospitalsClinicsPharmaciesPharmaceutical industry

Quality and Regulatory Approval

As a manufacturer of GMP-compliant medicinal products, the company is registered with EUDRA and is subject to supervision by the BfArM (Federal Opium Office) as well as, in matters of drug safety, by the Hannover Trade Supervisory Office. In-house analytics and process engineering equipment enable the supply of the full spectrum of cannabis-based active ingredients; the substances are delivered in accordance with monographs (DAC/DAB, Ph. Eur.) or with an in-house specification and certificate of analysis (CoA).

EvidenceAuetal
GMP-compliant manufacturing (EUDRA-registered)
License under § 4 MedCanG
ISO 9001

History

  1. 2016

    Foundation of alpha-cannabis Pharma GmbH with an exclusive focus on the medical potential of cannabinoids

Personalised demo

Ready to see Amplifa Marketplace in action?

From a structured request to the right manufacturing partner: AI-assisted matching, verified suppliers and transparent metrics — in one place for industrial companies across the DACH region.

Request a demo